Top Gainers and Losers on July 11: IREDA, BSE, BEML, TCS, MCX among top losers today
Indian stock market closed lower on July 11 with Sensex down 237 points. IREDA, BSE, TCS, and MCX among top losers; Divi’s Labs and HAL gained. Market outlook and analysis inside.

Market Wrap: Benchmarks End Lower Amid Mixed Global Cues
On Thursday, July 11, Indian equity benchmarks closed in the red as weak global cues and profit booking in PSU, IT, and financial stocks weighed on investor sentiment. The BSE Sensex shed over 200 points, while the Nifty 50 struggled to hold the 25,400 mark in a volatile session. Broader indices mirrored the trend with significant declines seen in mid-cap and small-cap segments.
Key Indices Performance:
-
BSE Sensex: Down 237.72 points or 0.31% at 83,291.41
-
Nifty 50: Down 67.10 points or 0.26% at 25,354.95
-
Nifty Midcap 100: Down 0.70%
-
Nifty Smallcap 100: Down 1.12%
Top Losers: Profit Booking Hits PSU, IT, and Exchange Stocks
Several high-profile stocks from PSU, IT, and capital goods segments witnessed selling pressure on July 11, driven by valuation concerns and global uncertainties.
1. Indian Renewable Energy Development Agency (IREDA)
-
Loss: Down 5.9%
-
IREDA continued its slide for the third straight session, as investors booked profits following the recent rally. Concerns around high valuations and sustainability of earnings growth in the renewable financing sector also contributed to the fall.
2. BSE Ltd
-
Loss: Down 5.3%
-
Shares of the Bombay Stock Exchange took a hit amid volatility in the broader markets and lack of strong trading volume triggers. Analysts pointed out that regulatory tightening in the SME segment and subdued derivatives participation might be impacting exchange revenue prospects.
3. BEML Ltd
-
Loss: Down 4.8%
-
BEML saw sharp profit-taking after its recent gains linked to defence and metro rail order wins. Analysts noted the stock had run up nearly 30% in the past month, inviting a near-term correction.
4. Tata Consultancy Services (TCS)
-
Loss: Down 1.7%
-
Despite posting better-than-expected Q1FY26 earnings a day earlier, TCS shares slipped as investors focused on the company's cautious revenue guidance for the rest of the financial year. Weak discretionary tech spending in key US and European markets remains a headwind.
“TCS results were strong in terms of margins, but the lack of visibility in BFSI and Retail verticals is making investors cautious. We may see sector-wide consolidation,” said Amit Nigam, CIO, Hem Securities.
5. Multi Commodity Exchange (MCX)
-
Loss: Down 4.5%
-
MCX shares faced pressure after reports suggested that increased regulatory oversight and changes in transaction fees could dent margins. Additionally, subdued activity in base metal and energy segments further weighed on sentiment.
Top Gainers: Selective Buying in Pharma, FMCG, and Infra Counters
While the broader market mood remained subdued, some counters managed to buck the trend due to sector-specific tailwinds and strong earnings expectations.
1. Divi’s Laboratories
-
Gain: Up 3.1%
-
Divi’s Lab surged on expectations of improving margins and stable demand in generics and custom synthesis segments. Pharma stocks have been gaining traction as defensive bets in a volatile market.
2. Hindustan Aeronautics Ltd (HAL)
-
Gain: Up 2.6%
-
HAL continued to rally on the back of strong order flows and increased focus on defence indigenisation by the Indian government. The stock also benefited from fresh institutional buying.
3. Dabur India
-
Gain: Up 1.9%
-
Dabur’s gains were driven by improved monsoon prospects and hopes of rural demand revival. FMCG stocks broadly saw some traction as investors rotated out of high-beta sectors.
4. L&T
-
Gain: Up 1.6%
-
Larsen & Toubro advanced after the company announced fresh orders worth over ₹3,000 crore in its power and water infrastructure segments. The move reflects a steady capex revival in India.
Sectoral Snapshot: IT, PSU, Capital Goods Drag; Pharma, FMCG Shine
-
Losers:
-
Nifty PSU Bank index fell 1.8%
-
Nifty IT declined 0.9%
-
Nifty Capital Goods dropped 1.3%
-
-
Gainers:
-
Nifty Pharma up 0.6%
-
Nifty FMCG gained 0.5%
-
Nifty Infra closed flat with a positive bias
-
“After a strong run-up in the past few weeks, market participants are taking a cautious stance. IT earnings season is underway, and the cautious outlook from TCS has added some nervousness,” said Nirali Shah, Head of Equity Research, Samco Securities.
Global Market Cues: Fed Signals and Oil Prices Weigh
Global markets traded mixed on Thursday as investors digested the US Fed Chair Jerome Powell’s remarks suggesting that inflation is still above the comfort zone. Asian markets largely closed flat to negative, while European indices opened marginally lower.
Crude oil prices also dipped below $84 per barrel as OPEC demand outlook weakened, adding pressure on energy-linked equities.
Investor Outlook: Near-Term Consolidation Likely
With earnings season picking up pace and global economic uncertainties persisting, analysts expect the Indian markets to witness a phase of consolidation in the coming sessions.
“Valuations are elevated across mid and small caps. Any earnings miss could trigger sharp corrections. Investors should stick to quality large-caps and keep a diversified portfolio,” advised Devang Mehta, Equity Strategist at Centrum Broking.
July 11 saw a clear divergence between defensives and high-beta names. While profit-booking hit top performers from the PSU, IT, and capital goods space, some resilience was observed in sectors like pharma, FMCG, and defence. As earnings season progresses, stock-specific moves are expected to dominate, with caution likely to prevail until clearer global and domestic signals emerge.
What's Your Reaction?






